
Scientists at Rice University were able to use plasmonic nanobubbles to find and destroy implanted human prostate cancer cells.
Dmitri Lapotko showed that the nanobubbles, generated around gold nanoparticles with a laser pulse, could detect and destroy cancer cells in vivo by creating tiny, shiny vapour bubbles that reveal the cells and selectively explode them.
Advertisement
Their animal model, the zebra fish, is nearly transparent, which makes it ideal for such in vivo research. The study has important implications in theranostics of cancer and other diseases at the cellular level.
First a short laser pulse overheated the surface of the nanoparticles and evaporated a very thin volume of the surrounding medium to create small vapour bubbles that expanded and collapsed within nanoseconds; this left cells undamaged but generated a strong optical scattering signal that was bright enough to detect a single cancer cell.
A second, stronger pulse generated larger nanobubbles that exploded the target cell without damaging surrounding tissue in the zebra fish. Scattering of the laser light by the second "killer" bubble confirmed the cellular destruction.
The nanobubbles avoid the pitfalls of chemo or radiative therapy that can damage healthy tissue as well as tumours.
"It's not a particle that kills the cancer cell, but a transient and short event. We're converting light energy into mechanical energy," Lapotko said.
"Being a stealth, on-demand probe with tunable function, the plasmonic nanobubble can be applied to all areas of medicine, since the nanobubble mechanism is universal and can be employed for detecting and manipulating specific molecules, or for precise microsurgery."
The study is published in the October print edition of the journal Biomaterials.
Source: ANI
Advertisement
A second, stronger pulse generated larger nanobubbles that exploded the target cell without damaging surrounding tissue in the zebra fish. Scattering of the laser light by the second "killer" bubble confirmed the cellular destruction.
The nanobubbles avoid the pitfalls of chemo or radiative therapy that can damage healthy tissue as well as tumours.
"It's not a particle that kills the cancer cell, but a transient and short event. We're converting light energy into mechanical energy," Lapotko said.
"Being a stealth, on-demand probe with tunable function, the plasmonic nanobubble can be applied to all areas of medicine, since the nanobubble mechanism is universal and can be employed for detecting and manipulating specific molecules, or for precise microsurgery."
The study is published in the October print edition of the journal Biomaterials.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.

A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.

Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.

Examining breast cancer occurrence and stages reveals disparities in urban versus rural rates, influenced by environmental conditions and the stage of the disease.

Polymerases theta and delta assist in the development of new cancer drugs known as polymerase theta inhibitors, currently undergoing clinical trials.